Davis Polk advised the joint book-running managers in the offering.Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed on…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now